31 search results for: biomarkers

ERS 2023 | Type 2 <b>Biomarkers</b> as Predictive and Prognostic Tools to Guide Management
expert video

ERS 2023 | Type 2 Biomarkers as Predictive and Prognostic Tools to Guide Management

Pulmonology
Prof. Vibeke Backer discusses the predictive and prognostic importance of the various biomarkers of type 2 inflammation in adult asthma.
View more
The Role of <b>Biomarkers</b> in Clinical Decision-Making in Atopic Dermatitis
expert video

The Role of Biomarkers in Clinical Decision-Making in Atopic Dermatitis

Dermatology
Dr. Stephan Weidinger talks about the role of biomarkers and their impact on clinical decision-making.
View more
The Current and Potential Future Roles of <b>Biomarkers</b> and Precision Medicine in CSU Clinical Management
expert video

The Current and Potential Future Roles of Biomarkers and Precision Medicine in CSU Clinical Management

Dermatology
Drs. Kim and Saini explore the potential future roles of biomarkers and precision medicine in CSU clinical management.
View more
ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis
Podcast

ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis

Dermatology
Prof. Thomas Bieber explores early intervention and disease modification in atopic dermatitis.
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
Treatment Goals, Current and Emerging Therapies in CSU
expert video

Treatment Goals, Current and Emerging Therapies in CSU

Dermatology
Drs. Maurer and Ensina delve into their thoughts on the latest treatment goals and emerging therapies for CSU in this illuminating interview.
View more
Latest Real-World Data on Advanced Systemic Treatments for Patients With AD
expert video

Latest Real-World Data on Advanced Systemic Treatments for Patients With AD

Dermatology
This video from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, features Dr. Marjolein de-Bruin Weller discussing the latest real-world data on the effects of advanced systemic treatments on multiple outcomes including disease activity, patient-reported outcomes, biomarkers, and atopic comorbidities in patients with AD.
View more
ADVENT On Air | Role of Type 2 Inflammation in COPD
Podcast

ADVENT On Air | Role of Type 2 Inflammation in COPD

Pulmonology
Drs Stephanie Christenson and Jean Bourbeau explore the role of type 2 inflammation in Chronic Obstructive Pulmonary Disease (COPD).
View more
ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​
expert video

ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​

Pulmonology
Join Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni for an educational program on the topic of clinical remission in severe asthma.
View more
CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis
Infographic

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

Dermatology
An infographic to explore the the key roles of CCL17 (TARC) in atopic dermatitis.
View more
FeNO as a Biomarker for Type 2 Asthma
expert video

FeNO as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Eugene Bleecker presents the utility of FeNO as a biomarker of type 2 inflammation, and its role in the disease burden of asthma.
View more
IgE as a Biomarker for Type 2 Asthma
expert video

IgE as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Jonathan Corren describes the diagnostic, predictive, and prognostic role of IgE as a biomarker of type 2 inflammation in asthma.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ChinaChange country/region